• 1
    Shattock RJ, Haynes BF, Pulendran B, Flores J, Esparza J: Improving Defences at the Portal of HIV Entry: Mucosal and Innate Immunity. PLoS Med 2008; 5:e81. doi: 10.1371/journal.pmed.0050081
  • 2
    Chahine BG, Bahna SL: The role of the gut mucosal immunity in the development of tolerance versus development of allergy to food. Curr Opin Allergy Clin Immunol 2010; 10:394399.
  • 3
    Gorfu G, Rivera-Nieves J, Ley K: Role of beta7 integrins in intestinal lymphocyte homing and retention. Curr Mol Med. 2009; 9:836850.
  • 4
    Lyons A, Longfield J, Kuschner R, Straight T, Binn L, Seriwatana J, Reitstetter R, Froh IB, Craft D, McNabb K, Russell K, Metzgar D, Liss A, Sun X, Towle A, Sun WA: Double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults. Vaccine 2008; 26:28902898.
  • 5
    Renegar KB, Small PA Jr, Boykins LG, Wright PF: Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J Immunol 2004; 173:19781986.
  • 6
    Wright PF, Kozlowski PA, Rybczyk GK, Goepfert P, Staats HF, VanCott TC, Trabattoni D, Sannella E, Mestecky J: Detection of mucosal antibodies in HIV type 1-infected individuals. AIDS Res Hum Retroviruses 2002; 18:129112300.
  • 7
    Einstein MH, Schiller JT, Viscidi RP, Strickler HD, Coursaget P, Tan T, Halsey N, Jenkins D: Clinician’s guide to human papillomavirus immunology: knowns and unknowns. Lancet Infect Dis. 2009; 9:347356.
  • 8
    Bennett JV, Fernandez de Castro J, Valdespino-Gomez JL, de Lourdes Garcia-Garcia M, Islas-Romero R, Echaniz-Aviles G, Jimenez-Corona A, Sepulveda-Amor J: Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren. Bull World Health Organ 2002; 80:806812.
  • 9
    Ogra PL, Karzon DT, Righthand F, MacGillivray M: Immunoglobulin Response in Serum and Secretions after Immunization with Live and Inactivated Poliovaccine and Natural Infection. N Engl J Med 1968; 279:893900.
  • 10
    Cuba IPV Study Collaborative Group: Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba. N Engl J Med 2007; 356:15361544.
  • 11
    Johnson PR, Feldman S, Thompson JM, Mahoney JD, Wright PF: Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J Infect Dis 1986; 154:121127.
  • 12
    Mestecky J, Wright PF, Lopalco L, Staats HL, Kozlowski PA, Moldoveanu Z, Alexander RC, Kulhavy R, Pastori C, Maboko L, Riedner G, Geis S, Hoelscher M, Zhu YW, Wrinn T: Correlates of Protection against HIV-1: absence of Humoral Immune Responses in the Plasma and Cervicovaginal Lavage Fluids of Heavily HIV-1-exposed but Uninfected Women. Accepted JAIDS.
  • 13
    Mutsch M, Zhou W, Rhodes P, Bopp M, Chen RT, Linder T, Spyr C, Steffen R: Use of the inactivated intranasal influenza vaccine and the risk of Bell’s palsy in Switzerland. N Engl J Med 2004; 350:896903.
  • 14
    Sur D, Lopez AL, Kanungo S, Paisley A, Manna B, Ali M, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Nguyen TV, Donner A, Ganguly NK, Nair GB, Bhattacharya SK, Clemens JD: Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet 2009; 374:16941702.
  • 15
    Wright PF, Tajima T, Thompson J, Kokubun K, Kapikian A, Karzon DT: Candidate rotavirus vaccine (rhesus rotavirus strain) in children: an evaluation. Pediatrics 1987; 80:473480.
  • 16
    Tomaras GD, Haynes BF: HIV-1-specific antibody responses during acute and chronic HIV-1 infection. Curr Opin HIV AIDS 2009; 4:373379.